HM
HealthCor Management Portfolio holdings
AUM
$109M
This Quarter Return
-0.12%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$1.74B
AUM Growth
+$1.74B
(+8.9%)
Cap. Flow
+$167M
Cap. Flow
% of AUM
9.58%
Top 10 Holdings %
Top 10 Hldgs %
58%
Holding
52
New
15
Increased
12
Reduced
9
Closed
12
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
$157M |
| 2 |
Intuitive Surgical
ISRG
|
$111M |
| 3 |
AET
Aetna Inc
AET
|
$104M |
| 4 |
Quest Diagnostics
DGX
|
$88.8M |
| 5 |
Danaher
DHR
|
$78.2M |
Top Sells
| 1 |
Biogen
BIIB
|
$117M |
| 2 |
Edwards Lifesciences
EW
|
$109M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$77.1M |
| 4 |
Cigna
CI
|
$76M |
| 5 |
Eli Lilly
LLY
|
$66.2M |
Sector Composition
| 1 | Healthcare | 82.12% |
| 2 | Financials | 5.97% |
| 3 | Consumer Staples | 3.94% |
| 4 | Materials | 0.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
1
DELISTED
Celgene Corp
CELG
| $174M | 9.81% | 1,500,000 +1,356,150 | +943% | +$157M |
|
2
Labcorp
LH
$23.1B
| $148M | 8.34% | 1,150,000 +400,000 | +53% | +$51.4M |
|
|
3
Intuitive Surgical
ISRG
$170B
| $111M | 6.27% | +175,000 | New | +$111M |
|
|
AET
4
DELISTED
Aetna Inc
AET
| $104M | 5.88% | +839,030 | New | +$104M |
|
|
5
Quest Diagnostics
DGX
$20.3B
| $103M | 5.84% | 1,125,000 +966,220 | +609% | +$88.8M |
|
|
QGENF
6
DELISTED
QIAGEN NV
QGENF
| $79.9M | 4.51% | 2,850,000 +575,000 | +25% | +$16.1M |
|
|
7
Danaher
DHR
$147B
| $78.2M | 4.42% | +1,004,650 | New | +$78.2M |
|
8
Incyte
INCY
$16.5B
| $74.3M | 4.2% | 741,360 +141,360 | +24% | +$14.2M |
|
9
Zimmer Biomet
ZBH
$21B
| $69.6M | 3.94% | 674,760 -375,240 | -36% | -$38.7M |
|
|
WOOF
10
DELISTED
VCA Inc.
WOOF
| $68.7M | 3.88% | +1,000,000 | New | +$68.7M |
|
11
UnitedHealth
UNH
$281B
| $65.2M | 3.69% | +407,580 | New | +$65.2M |
|
12
BioMarin Pharmaceuticals
BMRN
$11.2B
| $64.2M | 3.63% | +775,000 | New | +$64.2M |
|
|
SYNH
13
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $59.1M | 3.34% | 1,123,920 +123,920 | +12% | +$6.52M |
|
|
14
Cigna
CI
$80.3B
| $57.4M | 3.24% | 430,140 -569,860 | -57% | -$76M |
|
15
Pacira BioSciences
PCRX
$1.2B
| $50.9M | 2.87% | 1,575,000 +830,720 | +112% | +$26.8M |
|
16
Haemonetics
HAE
$2.63B
| $46.2M | 2.61% | +1,150,000 | New | +$46.2M |
|
17
Encompass Health
EHC
$12.3B
| $41.3M | 2.33% | 1,000,524 -649,476 | -39% | -$26.8M |
|
18
Neurocrine Biosciences
NBIX
$13.8B
| $38.3M | 2.16% | +988,900 | New | +$38.3M |
|
19
Merck
MRK
$210B
| $33.4M | 1.89% | 567,470 -232,530 | -29% | -$13.7M |
|
|
ALXN
20
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $32M | 1.81% | 261,140 -388,860 | -60% | -$47.6M |
|
|
CLVS
21
DELISTED
Clovis Oncology, Inc.
CLVS
| $27.8M | 1.57% | 625,000 -75,000 | -11% | -$3.33M |
|
|
BCR
22
DELISTED
CR Bard Inc.
BCR
| $24.1M | 1.36% | 107,370 -92,630 | -46% | -$20.8M |
|
23
DexCom
DXCM
$29.5B
| $22.6M | 1.28% | +378,650 | New | +$22.6M |
|
24
Collegium Pharmaceutical
COLL
$1.22B
| $22.2M | 1.25% | 1,426,300 +26,300 | +2% | +$409K |
|
25
Hologic
HOLX
$14.9B
| $18.1M | 1.03% | 452,340 -1,447,660 | -76% | -$58.1M |
|